牲畜驱虫剂市场机会、成长动力、产业趋势分析与预测 2025 - 2034

Livestock Dewormers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月14日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球牲畜驱虫剂市场价值为 79 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 4.8%。肉类和牛奶消费量的增加需要有效的畜群健康管理来最大限度地提高生产力。牲畜体内的寄生虫感染会严重阻碍其生长和产量，因此驱虫剂在牲畜保健中起着至关重要的作用。严格的食品安全法规、政府对兽医健康的支持以及农民对寄生虫感染造成的经济损失的认识不断提高，正在促进市场的发展。亚太、拉丁美洲和非洲的发展中地区也做出了巨大贡献，牲畜数量的增加和兽医基础设施的投资推动了需求。

牲畜驱虫药或驱虫药针对的是牛、羊、山羊、猪和家禽等动物体内的蛔虫、绦虫和吸虫等寄生虫。牛市占据了市场主导地位，到 2024 年市场规模将达到 36 亿美元。集约化农业实践的采用和对食品安全的日益重视进一步推动了这一领域的突出地位。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	79亿美元
预测值	124亿美元
复合年增长率	4.8％

按药物类别划分，大环内酯在 2024 年占据最大的市场份额，为 41%。它们的多功能性，加上註射剂和浇注剂等多样化剂型，确保了它们广泛应用于各种牲畜。

市场也按购买方式进行细分，非处方 (OTC) 类别获得了显着的关注，预计到 2034 年将达到 84 亿美元。这些产品消除了对兽医处方的需求，为寄生虫控制提供了经济高效且方便的解决方案。

口服驱虫药因其易于使用和成本效益而成为 2024 年的首选给药途径。片剂和粉末等产品无需专门的设备即可有效输送活性成分。缓释配方等创新进一步增强了它们的吸引力。

预计 2025 年至 2034 年期间，兽医药局的复合年增长率为 4.4%，成为驱虫产品的重要配销通路。它们的增长归功于农民对定期驱虫意识的提高，以及在专家指导下购买产品的便利性。

2024 年，美国占据了北美市场的很大份额，价值 31 亿美元，因为美国重视牲畜健康和动物寄生虫感染的流行。

The Global Livestock Dewormers Market, valued at USD 7.9 billion in 2024, is projected to expand at a CAGR of 4.8% from 2025 to 2034. This growth is fueled by the increasing global demand for animal protein and dairy products, driven by population growth and urbanization. Rising meat and milk consumption necessitates effective herd health management to maximize productivity. Parasitic infestations in livestock significantly hinder growth and yield, emphasizing the critical role of dewormers in livestock healthcare. Stringent food safety regulations, government support for veterinary health, and growing awareness among farmers about the economic losses caused by parasitic infections are bolstering the market. Developing regions in Asia-Pacific, Latin America, and Africa are also contributing significantly, with expanding livestock populations and investments in veterinary infrastructure driving demand.

Livestock dewormers, or anthelmintics, target parasitic worms such as roundworms, tapeworms, and flukes in animals like cattle, sheep, goats, swine, and poultry. The cattle segment dominated the market, reaching USD 3.6 billion in 2024. Cattle-specific dewormers are in high demand due to the susceptibility of cattle to parasitic infections that affect growth, milk production, and overall health. The adoption of intensive farming practices and the growing emphasis on food safety further drive this segment's prominence.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$7.9 Billion
Forecast Value	$12.4 Billion
CAGR	4.8%

By drug class, macrocyclic lactones held the largest market share at 41% in 2024. These compounds, known for their broad-spectrum efficacy and long-lasting action, are effective against internal parasites. Their versatility, combined with diverse formulations like injectables and pour-ons, ensures their widespread use across livestock species.

The market is also segmented by mode of purchase, with the over-the-counter (OTC) category gaining significant traction and expected to reach USD 8.4 billion by 2034. OTC dewormers are popular among farmers due to their accessibility, affordability, and ease of use. These products eliminate the need for veterinary prescriptions, offering cost-effective and convenient solutions for parasitic control.

Oral dewormers emerged as the preferred route of administration in 2024, driven by their ease of use and cost-effectiveness. Products such as tablets and powders allow efficient delivery of active ingredients without specialized equipment. Innovations like slow-release formulations further enhance their appeal.

Veterinary pharmacies are expected to grow at a CAGR of 4.4% from 2025 to 2034, serving as a vital distribution channel for deworming products. Their growth is attributed to increased awareness among farmers about regular deworming and the convenience of purchasing products with expert guidance.

In 2024, the US accounted for a significant share of the North American market, valued at USD 3.1 billion, due to its focus on livestock health and the prevalence of parasitic infections in animals.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing livestock population
  - 3.2.1.2 Rise in zoonotic diseases
  - 3.2.1.3 Supportive government policies
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Anthelmintic resistance
  - 3.2.2.2 Focus on organic and natural farming
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Cattle
5.3 Swine
5.4 Poultry
5.5 Other animal types

Chapter 6 Market Estimates and Forecast, By Drug Class, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Benzimidazoles
6.3 Macrocyclic lactones
6.4 Imidazothiazoles
6.5 Other drug classes

Chapter 7 Market Estimates and Forecast, By Mode, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 OTC
7.3 Prescription

Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 Oral
8.3 Topical
8.4 Parenteral

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)

9.1 Key trends
9.2 Veterinary pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 India
- 10.4.3 Japan
- 10.4.4 Australia
- 10.4.5 South Korea
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE